Department of Equine and Small Animal Medicine, University of Helsinki, Helsinki, Finland.
Acta Vet Scand. 2012 Sep 21;54(1):55. doi: 10.1186/1751-0147-54-55.
Ketoprofen is a non-steroidal anti-inflammatory drug which has been widely used for domestic animals. Orally administered racemic ketoprofen has been reported to be absorbed well in pigs, and bioavailability was almost complete. The objectives of this study were to analyze R- and S-ketoprofen concentrations in plasma after oral (PO) and intra muscular (IM) routes of administration, and to assess the relative bioavailability of racemic ketoprofen for both enantiomers between those routes of administration in growing pigs.
Eleven pigs received racemic ketoprofen at dose rates of 4 mg/kg PO and 3 mg/kg IM in a randomized, crossover design with a 6-day washout period. Enantiomers were separated on a chiral column and their concentrations were determined by liquid chromatography-tandem mass spectrometry. Pharmacokinetic parameters were calculated and relative bioavailability (Frel) was determined for S and R -ketoprofen.
S-ketoprofen was the predominant enantiomer in pig plasma after administration of the racemic mixture via both routes. The mean (± SD) maximum S-ketoprofen concentration in plasma (7.42 mg/L ± 2.35 in PO and 7.32 mg/L ± 0.75 in IM) was more than twice as high as that of R-ketoprofen (2.55 mg/L ± 0.99 in PO and 3.23 mg/L ± 0.70 in IM), and the terminal half-life was three times longer for S-ketoprofen (3.40 h ± 0.91 in PO and 2.89 h ± 0.85 in IM) than R-ketoprofen (1.1 h ± 0.90 in PO and 0.75 h ± 0.48 in IM). The mean (± SD) relative bioavailability (PO compared to IM) was 83 ± 20% and 63 ± 23% for S-ketoprofen and R-ketoprofen, respectively.
Although some minor differences were detected in the ketoprofen enantiomer concentrations in plasma after PO and IM administration, they are probably not relevant in clinical use. Thus, the pharmacological effects of racemic ketoprofen should be comparable after intramuscular and oral routes of administration in growing pigs.
酮洛芬是一种被广泛应用于家畜的非甾体类抗炎药。已报道,经口给予外消旋酮洛芬后,其在猪体内吸收良好,生物利用度几乎达到 100%。本研究的目的是分析口服(PO)和肌肉内(IM)给药后血浆中 R-和 S-酮洛芬的浓度,并评估这两种给药途径下外消旋酮洛芬对两种对映体的相对生物利用度。
11 头猪采用随机交叉设计,在 6 天洗脱期内分别以 4mg/kg PO 和 3mg/kg IM 的剂量接受外消旋酮洛芬。采用手性柱分离对映体,并用液相色谱-串联质谱法测定其浓度。计算药代动力学参数,并确定 S-和 R-酮洛芬的相对生物利用度(Frel)。
两种途径给予外消旋混合物后,S-酮洛芬均为猪血浆中的主要对映体。PO 途径下 S-酮洛芬的最大血浆浓度(7.42mg/L±2.35)约为 R-酮洛芬(2.55mg/L±0.99)的两倍多,IM 途径下 S-酮洛芬的最大血浆浓度(7.32mg/L±0.75)约为 R-酮洛芬(3.23mg/L±0.70)的两倍多,S-酮洛芬的半衰期(3.40h±0.91)约为 R-酮洛芬(1.1h±0.90)的三倍。S-酮洛芬(PO 与 IM 相比)和 R-酮洛芬(PO 与 IM 相比)的平均(±SD)相对生物利用度分别为 83%±20%和 63%±23%。
虽然 PO 和 IM 给药后血浆中酮洛芬对映体浓度存在一些差异,但在临床应用中可能并不相关。因此,在生长猪中,外消旋酮洛芬经肌内和口服途径给药的药理作用应该是相当的。